BCL2 and neoplasm: In tumor cells isolated from patients on the trial, we noted a significant decrease in Bcl-2:Bim or Mcl-1:Noxa complexes after 1 full cycle of treatment, suggesting increased availability of Bim to trigger mitochondrial-mediated programmed cell death.